Prebiotics old and new
The prebiotics concept was introduced for initially in 1995 by Glenn Gibson and Marcel Roberfroid. Prebiotic was described as “a non-digestible food ingredient that beneficially affects the host by selectively stimulating the expansion and/or activity of 1 or a limited number of bacteria within the colon, and thus improves host health”. This definition was unchanged for quite 15 years. consistent with this definition, only a couple of compounds of the carbohydrate group, like short and long chain β-fructans [FOS and inulin], lactulose, and GOS, are often classified as prebiotics. In 2008, the 6th Meeting of the International Scientific Association of Probiotics and Prebiotic defined “dietary prebiotics” as “a selectively fermented ingredient that leads to specific changes within the composition and/or activity of the gastrointestinal microbiota, thus conferring benefits upon host health”.
Related Conference of Prebiotics old and new
22nd International Conference on Virology, Emerging Diseases & vaccines
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
13th International Congress on Trauma, Critical Care and Emergency Medicine
Prebiotics old and new Conference Speakers
Recommended Sessions
- Microbiome
- Pediatric and Infant Health
- Pre and Probiotics futures
- Prebiotics and Diet
- Prebiotics old and new
- Probiotics in Aquaculture
- Probiotics in food security
- Synbiotic
- Food and Fermentation
- Formulations and Production
- Gut Bacteria on COVID Severity
- Gut microbiota
- Microbiota from womb to adult
- Microbiota Protection and Resilience
- New Methods and New Equipment
- Nutrition and Probiotics
- Preterm and term Newborns Probiotics
- Probiotics and COVID-19
- Probiotics in oral health and dentistry
- Probiotics in women’s health
Related Journals
Are you interested in
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Critical Care Medicine - TRAUMA 2027 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2027 (France)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2027 (France)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Global Health and Trauma Care - TRAUMA 2027 (France)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric and Neonatal Emergency Care - TRAUMA 2027 (France)
- Resuscitation and Emergency Response - TRAUMA 2027 (France)
- Trauma and Emergency Medicine - TRAUMA 2027 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2027 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2027 (France)
